JCI - Citations to Tregs and rethinking cancer immunotherapy

Citations to this article

Tregs and rethinking cancer immunotherapy

Tyler J. Curiel

Tyler J. Curiel

Published May 1, 2007
Citation Information: J Clin Invest. 2007;117(5):1167-1174. https://doi.org/10.1172/JCI31202.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	Total
Citations:	1	5	11	8	11	6	14	10	14	11	12	22	16	18	9	19	26	16	2	231

Citation information

Citations to this article (231)

Title and authors	Publication	Year
Deciphering the integrated immunogenomic landscape of colorectal cancer: insights from Mendelian randomization and immune-stratified molecular subtyping He KJ, Gong G	BMC Gastroenterology	2025
A novel enemy of cancer: recent investigations into protozoan anti-tumor properties Zheng Z, Lu X, Zhou D, Deng XF, Liu QX, Liu XB, Zhang J, Li YQ, Zheng H, Dai JG	Frontiers in Cellular and Infection Microbiology	2024
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma Joseph AM, Al Aiyan A, Al-Ramadi B, Singh SK, Kishore U	Frontiers in immunology	2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C	Nature Communications	2024
Mining parasites for their potential as novel therapeutic agents against cancer. Walter NS, Bhattacharyya S	Medical Oncology	2024
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, Wang Q, Li Y, Hu F, Ren H	Molecular cancer	2024
Parasites as potential targets for cancer immunotherapy. Yousefi M, Akbari M, Hadipour M, Dehkordi AB, Farahbakhsh Z, Darani HY	Journal of Cancer Research and Clinical Oncology	2023
Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models Moi D, Zeng B, Minnie SA, Bhatt R, Wood J, Sester DP, Mazzieri R, Dolcetti R	Frontiers in immunology	2023
CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach Zhang X, Hu Q, He X, Cui X, Liang Z, Wang L, Deng X, Zhang Z, Sheng W, Han XD	Journal of nanobiotechnology	2023
Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma Wu J, Wang S, Liu Y, Zhang T, Wang X, Miao C	Frontiers in immunology	2023
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma Wu J, Meng F, Ran D, Song Y, Dang Y, Lai F, Yang L, Deng M, Song Y, Zhu J	Metabolites	2023
The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials Chen S, Mo W, Jiang W, Zhou S, Gan H, Yu Q	Frontiers in immunology	2023
The roles of T cells in psoriasis Zhang P, Su Y, Li S, Chen H, Wu R, Wu H	Frontiers in immunology	2023
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state. Van Lint S, Van Parys A, Van Den Eeckhout B, Vandamme N, Plaisance S, Verhee A, Catteeuw D, Rogge E, De Geest J, Vanderroost N, Roels J, Saeys Y, Uzé G, Kley N, Cauwels A, Tavernier J	Molecular Cancer	2023
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C	medRxiv : the preprint server for health sciences	2023
Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring Gao Y, Chen S, Wang H, Wu C, An R, Li G, Yang M, Zhou Y, Zhou Y, Xie X, Yu H, Zhang J	Journal of Advanced Research	2023
Considerations and approaches for cancer immunotherapy in the aging host Ontiveros CO, Murray CE, Crossland G, Curiel TJ	Cancer immunology research	2023
EZH2 Catalytic Inhibition Prevents Urothelial Carcinoma Progression Through Immune Activation Andrea Piunti, Khyati Meghani, A. Robertson, Joseph Podojil, Yanni Yu, Kimberly McLaughlin, Zonghao You, Damiano Fantini, Alexander Glaser, Valerie Eaton, MingYi Chiang, Arighno Das, Stephen Miller, Ali Shilatifard, Joshua Meeks	Science Advances	2022
The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges Muller M, Haghnejad V, Schaefer M, Gauchotte G, Caron B, Peyrin-Biroulet L, Bronowicki JP, Neuzillet C, Lopez A	Cancers	2022
Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates Tang M, Jia F, Nan F, Zuo F, Yuan Z, Zhang D	Frontiers in immunology	2022
Autophagy-Dependent Ferroptosis-Related Signature is Closely Associated with the Prognosis and Tumor Immune Escape of Patients with Glioma Sun W, Yan J, Ma H, Wu J, Zhang Y	International journal of general medicine	2022
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects. Abdolahi S, Hosseini M, Rezaei R, Mohebbi SR, Rostami-Nejad M, Mojarad EN, Mirjalali H, Yadegar A, Asadzadeh Aghdaei H, Zali MR, Baghaei K	Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases	2022
Novel approach to analysis of the immune system using an ungated model of immune surface marker abundance to predict health outcomes Provost G, Lavoie FB, Larbi A, Ng T, Ying CT, Chua M, Fulop T, Cohen AA	Immunity & ageing : I & A	2022
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer Wang H, Liu J, Yang J, Wang Z, Zhang Z, Peng J, Wang Y, Hong L	Frontiers in immunology	2022
PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study Chen S, Wei H, Zhao W, Jiang W, Ning R, Zhou S, Tan L, Wang H, Su C, He J, Zeng A, Zhao Y, Yu Q	Frontiers in immunology	2022
The immunological and metabolic landscape in primary and metastatic liver cancer X Li, P Ramadori, D Pfister, M Seehawer, L Zender, M Heikenwalder	Nature Reviews Cancer	2021
Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression R Raja, C Wu, F Limbeck, K Butler, AP Acharya, M Curtis	Cancers	2021
The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer S Ren, X Xiong, H You, J Shen, P Zhou	Frontiers in immunology	2021
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8+ T Cells in Chinese Advanced Non–Small-Cell Lung Cancer Patients Treated With the Anti–PD-L1 Antibody J Sheng, H Wang, X Liu, Y Deng, Y Yu, P Xu, J Shou, H Pan, H Li, X Zhou, W Han, T Sun, H Pan, Y Fang	Frontiers in Molecular Biosciences	2021
Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant CF Teng, TC Li, T Wang, DC Liao, YH Wen, TH Wu, J Wang, HC Wu, WC Shyu, IJ Su, LB Jeng	Scientific Reports	2021
Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress Z Huang, Y Wang, D Yao, J Wu, Y Hu, A Yuan	Nature Communications	2021
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics A Jindal, S Sarkar, A Alam	Frontiers in Chemistry	2021
Curcumin as an Adjuvant to Cancer Immunotherapy S Paul, G Sa	Frontiers in Oncology	2021
A tumor-specific mechanism of T reg enrichment mediated by the integrin αvβ8 RI Seed, K Kobayashi, S Ito, N Takasaka, A Cormier, JM Jespersen, J Publicover, S Trilok, AJ Combes, NW Chew, J Chapman, MF Krummel, J Lou, J Marks, Y Cheng, JL Baron, SL Nishimura	Science Immunology	2021
Specific MiRNAs in naïve T cells associated with Hepatitis C Virus-induced Hepatocellular Carcinoma Yan P, Pang P, Hu X, Wang A, Zhang H, Ma Y, Zhang K, Ye Y, Zhou B, Mao J	Journal of Cancer	2021
Synthesis, spectral characterization, and biological studies of 3,5-disubstituted-1,3,4-oxadiazole-2(3H)-thione derivatives ÖZYAZICI T, ŞAHİN F, KÖKSAL M		2021
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade JM Drerup, Y Deng, SL Pandeswara, ÁS Padrón, RM Reyes, X Zhang, J Mendez, A Liu, CA Clark, W Chen, JR Conejo-Garcia, V Hurez, H Gupta, TJ Curiel	Cancer research	2020
At the Bench: Pre‐clinical evidence for multiple functions of CXCR4 in cancer GD Luker, J Yang, A Richmond, S Scala, C Festuccia, M Schottelius, HJ Wester, J Zimmermann	Journal of leukocyte biology	2020
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage? A Mennitto, V Huber, R Ratta, P Sepe, F de Braud, G Procopio, V Guadalupi, M Claps, M Stellato, E Daveri, L Rivoltini, E Verzoni	Journal of Clinical Medicine	2020
Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease R Stanzione, M Forte, M Cotugno, F Bianchi, S Marchitti, S Rubattu	Cellular and Molecular Neurobiology	2020
T-regulatory cell/T helper 17 cell imbalance functions as prognostic biomarker of oral squamous cell carcinoma – CONSORT L Wang, Y Zhang, F Xie	Medicine	2020
Specialized immune responses in the peritoneal cavity and omentum M Liu, A SilvaSanchez, TD Randall, S MezaPerez	Journal of leukocyte biology	2020
Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model D Adah, Y Yang, Q Liu, K Gadidasu, Z Tao, S Yu, L Dai, X Li, S Zhao, L Qin, L Qin, X Chen	Cell Communication and Signaling	2019
Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model Y Kim, D Lee, J Lee, S Lee, S Lawler, E Demidenko	PloS one	2019
Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis A Kogure, N Kosaka, T Ochiya	Journal of Biomedical Science	2019
Differences of the immune cell landscape between normal and tumor tissue in human prostate E Zhang, F Dai, Y Mao, W He, F Liu, W Ma, Y Qiao	Clinical and Translational Oncology	2019
Prognostic role of immune infiltrates in breast ductal carcinoma in situ XY Chen, J Yeong, AA Thike, BH Bay, PH Tan	Breast Cancer Research and Treatment	2019
Significant association of CD4+CD25+Foxp3+ regulatory T cells with clinical findings in patients with systemic lupus erythematosus X Yang, W Wang, J Xu, MS Zhang, H Mei, Y Shen, MJ Zhang, X Ji, H Wang	Annals of translational medicine	2019
CD4 + CD25 high CD127 low/- FoxP 3+ Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature M Niedźwiecki, O Budziło, E Adamkiewicz-Drożyńska, D Pawlik-Gwozdecka, M Zieliński, L Maciejka-Kembłowska, T Szczepański, P Trzonkowski	Journal of Immunology Research	2019
T Regulatory CD4+CD25+FoxP3+ Lymphocytes in the Peripheral Blood of Left-Sided Colorectal Cancer Patients K Dylag-Trojanowska, J Rogala, R Pach, M Siedlar, J Baran, M Sierzega, J Zybaczynska, M Lenart, M Rutkowska-Zapala, AM Szczepanik	MED LITH	2019
Cancer‐associated fibroblast‐derived interleukin‐1β activates protumor C‐C motif chemokine ligand 22 signaling in head and neck cancer YH Huang, CY Chang, YZ Kuo, WY Fang, HY Kao, ST Tsai, LW Wu	Cancer Science	2019
Antitumor immunity of low-dose cyclophosphamide: changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis XM Huang, NR Zhang, XT Lin, CY Zhu, YF Zou, XJ Wu, XS He, XW He, YL Wan, P Lan	Gastroenterology Report	2019
Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy A Gao, X Hu, M Saeed, B Chen, Y Li, H Yu	Acta Pharmacologica Sinica	2019
Novel Immunotherapy Combinations B Bashir, MA Wilson	Current Oncology Reports	2019
Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities Guilian Shi, Mingchuan Zhong, Fuli Ye, Xiaoming Zhang	Cancer biology & medicine	2019
Ginseng berry polysaccharides on inflammation-associated colon cancer: inhibiting T-cell differentiation, promoting apoptosis, and enhancing the effects of 5-fluorouracil. Wang CZ, Hou L, Wan JY, Yao H, Yuan J, Zeng J, Park CW, Kim SH, Seo DB, Shin KS, Zhang CF, Chen L, Zhang QH, Liu Z, Sava-Segal C, Yuan CS	Journal of Ginseng Research	2019
ImmTAC/Anti-PD-1 Combination to Enhance Killing of Cancer cells by Reversing Treg-mediated Immunosuppression H Zhang, Y Li, X Liu, Z Liang, M Yan, Q Liu, A Chen, Y Bao, C Zhou, S Li, C Yee, Y Li	Immunology	2018
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity D Wang, J Quiros, K Mahuron, CC Pai, V Ranzani, A Young, S Silveria, T Harwin, A Abnousian, M Pagani, MD Rosenblum, FV Gool, L Fong, JA Bluestone, M DuPage	Cell Reports	2018
Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells MY Fan, LA Turka	Frontiers in immunology	2018
Targeting VEGF/VEGFR to Modulate Antitumor Immunity J Yang, J Yan, B Liu	Frontiers in immunology	2018
Statin use and risk of skin cancer BM Lin, WQ Li, E Cho, GC Curhan, AA Qureshi	Journal of the American Academy of Dermatology	2018
CD4 + CD25 high CD127 low/− FoxP 3+ Regulatory T Cell Subpopulations in the Bone Marrow and Peripheral Blood of Children with ALL: Brief Report M Niedźwiecki, O Budziło, M Zieliński, E Adamkiewicz-Drożyńska, L Maciejka-Kembłowska, T Szczepański, P Trzonkowski	Journal of Immunology Research	2018
Role of regulatory T�cells and CD8+�T lymphocytes in the dissemination of circulating tumor cells in primary invasive breast cancer D Xue, T Xia, J Wang, M Chong, S Wang, C Zhang	Oncology Letters	2018
Effects of modified FOLFOX-6 chemotherapy on cellular immune function in patients with gastric cancer L Wang, D Zhou, H Ren, Y Chen	Oncology Letters	2018
Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy A Aleshin, PL Greenberg	Blood Advances	2018
Effect of polysaccharides from a Korean ginseng berry on the immunosenescence of aged mice M Kim, YS Yi, J Kim, SY Han, SH Kim, DB Seo, JY Cho, SS Shin	Journal of Ginseng Research	2018
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer S Santagata, M Napolitano, C D'Alterio, S Desicato, SD Maro, L Marinelli, A Fragale, M Buoncervello, F Persico, L Gabriele, E Novellino, N Longo, S Pignata, S Perdonà, S Scala	Oncotarget	2017
Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it? CM Hull, M Peakman, TI Tree	Diabetologia	2017
Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis L Cari, G Nocentini, G Migliorati, C Riccardi	OncoImmunology	2017
Forkhead-box transcription factor 1 affects the apoptosis of natural regulatory T cells by controlling Aven expression Z Cai, H Liu, X Wu	BMC Immunology	2017
Identification of key genes implicated in the suppressive function of human FOXP3+CD25+CD4+ regulatory T cells through the analysis of time‑series data X Bai, H Shi, M Yang, Y Wang, Z Sun, S Xu	Molecular medicine reports	2017
The effects of antiviral treatment on breast cancer cell line M Shaimerdenova, O Karapina, D Mektepbayeva, K Alibek, D Akilbekova	Infectious agents and cancer	2017
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy LM Aparicio, IP Fernandez, J Cassinello	Clinical and Translational Oncology	2017
MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells Z Zheng, PP Xu, L Wang, HJ Zhao, XQ Weng, HJ Zhong, B Qu, J Xiong, Y Zhao, XF Wang, A Janin, WL Zhao	Journal of Experimental & Clinical Cancer Research	2017
Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model E Oh, IK Choi, JW Hong, CO Yun	Oncotarget	2017
Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma J Zhang, B Wei, H Hu, F Liu, Y Tu, M Zhao, D Wu	Oncology Letters	2017
Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata	Oncology Letters	2017
Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma DE Meyers, S Thakur, CM Thirukkumaran, DG Morris	Blood Cancer Journal	2017
The in vivo T helper type 17 and regulatory T cell immune responses to Aggregatibacter actinomycetemcomitans S Mahabady, N Tjokro, S Aharonian, HH Zadeh, C Chen, H Allayee, PP Sedghizadeh	Molecular Oral Microbiology	2017
Interleukin 2 and interleukin 10 function synergistically to promote CD8⁺ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Li X, Lu P, Li B, Zhang W, Yang R, Chu Y, Luo K	The International Journal of Biochemistry & Cell Biology	2017
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity L Wang, S Kumar, S Dahiya, F Wang, J Wu, K Newick, R Han, A Samanta, UH Beier, T Akimova, TR Bhatti, B Nicholson, MP Kodrasov, S Agarwal, DE Sterner, W Gu, J Weinstock, TR Butt, SM Albelda, WW Hancock	EBioMedicine	2016
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment A Hanna, LA Shevde	Molecular Cancer	2016
Relation of statin use with non-melanoma skin cancer: prospective results from the Women’s Health Initiative A Wang, ML Stefanick, K Kapphahn, H Hedlin, M Desai, JA Manson, H Strickler, L Martin, J Wactawski-Wende, M Simon, JY Tang	British Journal of Cancer	2016
Interleukin-6 Induced “Acute” Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics T Xue, P Liu, Y Zhou, K Liu, L Yang, RL Moritz, W Yan, LX Xu	Theranostics	2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition S Ghosh, A Taylor, M Chin, HR Huang, AR Conery, JA Mertz, A Salmeron, PJ Dakle, D Mele, A Cote, H Jayaram, JW Setser, F Poy, G Hatzivassiliou, D DeAlmeida-Nagata, P Sandy, C Hatton, FA Romero, E Chiang, T Reimer, T Crawford, E Pardo, VG Watson, V Tsui, AG Cochran, L Zawadzke, JC Harmange, JE Audia, BM Bryant, RT Cummings, SR Magnuson, JL Grogan, SF Bellon, BK Albrecht, RJ Sims, JM Lora	The Journal of biological chemistry	2016
Bone morphogenetic protein 7 is associated with the nodal invasion of colon cancer T Zhang, J Fu, Y Li, Y Wang, L Zhang, Y Liu	Oncology Letters	2016
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer K Nosho	World journal of gastroenterology : WJG	2016
Considerations for successful cancer immunotherapy in aged hosts: Ageing and cancer immunotherapy V Hurez, ÁS Padrón, RS Svatek, TJ Curiel	Clinical & Experimental Immunology	2016
Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation YC Jou, YS Tsai, CT Lin, CL Tung, CH Shen, HT Tsai, WH Yang, HI Chang, SY Chen, TS Tzai	Oncotarget	2016
The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients Choi HS, Ha SY, Kim HM, Ahn SM, Kang MS, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kang ES	Oncotarget	2016
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma. Zloza A, Dharmadhikari ND, Huelsmann EJ, Broucek JR, Hughes T, Kohlhapp FJ, Kaufman HL	Cancer Immunology, Immunotherapy	2016
The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy MS Li, Z Liu, JQ Liu, X Zhu, Z Liu, XF Bai	Immunotherapy	2015
Association between Statin Use and Cancer: Data Mining of a Spontaneous Reporting Database and a Claims Database M Fujimoto, T Higuchi, K Hosomi, M Takada	International journal of medical sciences	2015
Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes SZ Zhang, XZ He, S Han, QF Wang, YY Ye, ZY Zhu, HQ Wang	Drug design, development and therapy	2015
Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells S Ronchetti, E Ricci, MG Petrillo, L Cari, G Migliorati, G Nocentini, C Riccardi	Journal of Immunology Research	2015
Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients S Zhu, J Lin, G Qiao, Y Xu, H Zou	Tumor Biology	2015
Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma J Bedke, S Kruck, G Gakis, A Stenzl, PJ Goebell	Human Vaccines & Immunotherapeutics	2015
Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer SB Ingersoll, S Ahmad, HC McGann, RK Banks, NM Stavitzski, M Srivastava, G Ali, NJ Finkler, JR Edwards, RW Holloway	Molecular and Cellular Biochemistry	2015
Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice M Takamatsu, A Hirata, H Ohtaki, M Hoshi, T Ando, H Ito, Y Hatano, H Tomita, T Kuno, K Saito, M Seishima, A Hara	Cancer Science	2015
Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression M Bu, Y Shen, WL Seeger, S An, R Qi, JA Sanderson, Y Cai	Tumor Biology	2015
Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma C Cai, J Zhang, M Li, ZJ Wu, KH Song, TW Zhan, LH Wang, YH Sun	Tumor Biology	2015
Statins and cancers A Stryjkowska-Góra, B Karczmarek-Borowska, T Góra, K Krawczak	WSPOLCZESNA ONKOL	2015
OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA	Oncotarget	2015
γδ T cells for cancer immunotherapy JP Fisher, J Heuijerjans, M Yan, K Gustafsson, J Anderson	OncoImmunology	2014
Complement anaphylatoxins as immune regulators in cancer ET Sayegh, O Bloch, AT Parsa	Cancer Medicine	2014
An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma Y Tang, X Xu, S Guo, C Zhang, Y Tang, Y Tian, B Ni, B Lu, H Wang	PloS one	2014
Critical stoichiometric ratio of CD4 + CD25 + FoxP3 + regulatory T cells and CD4 + CD25 − responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia K Bhattacharya, S Chandra, C Mandal	Immunology	2014
Spontaneous regression of metastatic cancer cells in the lymph node: a case report N Choi, JK Cho, CH Baek, YH Ko, HS Jeong	BMC Research Notes	2014
Characterization of an adaptive immune response in microsatellite-instable colorectal cancer F Boissière-Michot, G Lazennec, H Frugier, M Jarlier, L Roca, ED Paty, D Laune, F Blanchard, FL Pessot, JC Sabourin, F Bibeau	OncoImmunology	2014
Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer JY Li, XF Duan, LP Wang, YJ Xu, L Huang, TF Zhang, JY Liu, F Li, Z Zhang, DL Yue, F Wang, B Zhang, Y Zhang	Journal of Immunology Research	2014
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma P Monk, E Lam, A Mortazavi, K Kendra, GB Lesinski, TA Mace, S Geyer, WE 3rd, S Tahiri, A Bhinder, SK Clinton, T Olencki	Journal of immunotherapy (Hagerstown, Md. : 1997)	2014
Implementing combinatorial immunotherapeutic regimens against cancer D Wolf, A Heine, P Brossart	OncoImmunology	2014
Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance SK Ganapathi, AD Beggs, SV Hodgson, D Kumar	British Journal of Cancer	2014
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion PF Forde, M Sadadcharam, LJ Hall, TR Donovan, M Kruijf, WL Byrne, GC Sullivan, DM Soden	Cancer Gene Therapy	2014
Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis UB Hagemann, L Gunnarsson, S Géraudie, U Scheffler, RA Griep, H Reiersen, AR Duncan, SM Kiprijanov	PloS one	2014
Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients G Nocentini, A Alunno, MG Petrillo, O Bistoni, E Bartoloni, S Caterbi, S Ronchetti, G Migliorati, C Riccardi, R Gerli	Arthritis Research & Therapy	2014
Innate Antiviral Host Defense Attenuates TGF-β Function through IRF3-Mediated Suppression of Smad Signaling P Xu, S Bailey-Bucktrout, Y Xi, D Xu, D Du, Q Zhang, W Xiang, J Liu, A Melton, D Sheppard, HA Chapman, JA Bluestone, R Derynck	Molecular Cell	2014
Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection Y Chen, J Fang, X Chen, C Pan, X Liu, J Liu	Experimental and therapeutic medicine	2014
Analysis of FoxP3+ T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers C Hermans, D Anz, J Engel, T Kirchner, S Endres, D Mayr, D Unutmaz	PloS one	2014
STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer D Chandra, W Quispe-Tintaya, A Jahangir, D Asafu-Adjei, I Ramos, HO Sintim, J Zhou, Y Hayakawa, DK Karaolis, C Gravekamp	Cancer immunology research	2014
Exercise effects on polyp burden and immune markers in the ApcMin/+ mouse model of intestinal tumorigenesis J McClellan, J Steiner, S Day, R Enos, M Davis, U Singh, E Murphy	International journal of oncology	2014
Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma EJ Lipson, MA Bodell, ES Kraus, WH Sharfman	Journal of Clinical Oncology	2014
The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination. Miao ZF, Zhao TT, Miao F, Wang ZN, Xu YY, Mao XY, Gao J, Wu JH, Liu XY, You Y, Xu H, Xu HM	Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	2014
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction Kuehnle MC, Attig S, Britten CM, Schulze-Bergkamen H, Lordick F, von Wichert G, Thuss-Patience P, Stein A, Schuler M, Bassermann F, Sahin U, Türeci Ö	Cancer Immunology, Immunotherapy	2014
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity. Alteber Z, Azulay M, Cafri G, Vadai E, Tzehoval E, Eisenbach L	Cancer Immunology, Immunotherapy	2014
Intratumoral Immunomodulation at a Single Site Cures Disseminated Disease Including in the Brain Aurelien Marabelle, Holbrook Kohrt, Idit sagiv-barfi, bahareh ajami, Robert Axtell, Gang Zhou, ranjani rajapaksa, Michael Green, James Torchia, Joshua Brody, Richard Luong, Michael D Rosenblum, Lawrence Steinman, Hyam Levitsky, Victor Tse, Ronald Levy	Journal of Clinical Investigation	2013
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors J Duraiswamy, KM Kaluza, GJ Freeman, G Coukos	Cancer research	2013
NF-κB: roles and regulation in different CD4(+) T-cell subsets H Oh, S Ghosh	Immunological Reviews	2013
Bone marrow provides an environment that prevents suppression of therapeutic graft-vs.-tumor immunity by regulatory T cells T Guichelaar, T Mutis	OncoImmunology	2013
Influence of tumors on protective anti-tumor immunity and the effects of irradiation GA Foulds, J Radons, M Kreuzer, G Multhoff, AG Pockley	Frontiers in Oncology	2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer S Wada, CM Jackson, K Yoshimura, HR Yen, D Getnet, TJ Harris, MV Goldberg, TC Bruno, JF Grosso, N Durham, GJ Netto, DM Pardoll, CG Drake	Journal of Translational Medicine	2013
The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities ME Freiser, P Serafini, DT Weed	Immunologic Research	2013
Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy J Bedke, C Gouttefangeas, H Singh-Jasuja, S Stevanović, CL Behnes, A Stenzl	World Journal of Urology	2013
Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy M Kobayashi, T Kubo, K Komatsu, A Fujisaki, F Terauchi, S Natsui, A Nukui, S Kurokawa, T Morita	Medical Oncology	2013
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients EC Zeestraten, MS Reimers, S Saadatmand, JW Dekker, GJ Liefers, PJ van Elsen, CJ van de Velde, PJ Kuppen	British Journal of Cancer	2013
Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1 M Singh, I Ramos, D Asafu-Adjei, W Quispe-Tintaya, D Chandra, A Jahangir, X Zang, BB Aggarwal, C Gravekamp	Cancer Medicine	2013
Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer YQ Li, FF Liu, XM Zhang, XJ Guo, MJ Ren, L Fu	PloS one	2013
What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer? RN Ramos, CJ de Moraes, B Zelante, JA Barbuto	Clinical & developmental immunology	2013
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance C Bryant, H Suen, R Brown, S Yang, J Favaloro, E Aklilu, J Gibson, PJ Ho, H Iland, P Fromm, N Woodland, N Nassif, D Hart, DE Joshua	Blood Cancer Journal	2013
Antigen-Specific Memory Regulatory CD4 + Foxp3 + T Cells Control Memory Responses to Influenza Virus Infection EL Brincks, AD Roberts, T Cookenham, S Sell, JE Kohlmeier, MA Blackman, DL Woodland	Journal of immunology (Baltimore, Md. : 1950)	2013
Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer. Homma Y, Taniguchi K, Nakazawa M, Matsuyama R, Mori R, Takeda K, Ichikawa Y, Tanaka K, Endo I	Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico	2013
Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy A Park, C Govindaraj, SD Xiang, J Halo, M Quinn, K Scalzo-Inguanti, M Plebanski	Cancers	2012
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype D Hirschhorn-Cymerman, S Budhu, S Kitano, C Liu, F Zhao, H Zhong, AM Lesokhin, F Avogadri-Connors, J Yuan, Y Li, AN Houghton, T Merghoub, JD Wolchok	Journal of Experimental Medicine	2012
The Ambiguity in Immunology V Barnaba, M Paroli, S Piconese	Frontiers in immunology	2012
Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice J Yan, F Hua, H Liu, H Yang, Z Hu	Acta Pharmacologica Sinica	2012
Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF P Spear, A Barber, A Rynda-Apple, CL Sentman	Journal of immunology (Baltimore, Md. : 1950)	2012
Tumor-Infiltrating T Lymphocytes Predict Clinical Outcome in Human Breast Cancer C Ma, Q Zhang, J Ye, F Wang, Y Zhang, E Wevers, T Schwartz, P Hunborg, MA Varvares, DF Hoft, EC Hsueh, G Peng	Journal of immunology (Baltimore, Md. : 1950)	2012
Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve? TN Nguyen-Pham, YK Lee, HJ Kim, JJ Lee	Clinical and Developmental Immunology	2012
Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer WJ Fávaro, OS Nunes, FR Seiva, IS Nunes, LK Woolhiser, N Durán, AJ Lenaerts	Infectious agents and cancer	2012
Immunotherapy: A useful strategy to help combat multidrug resistance TJ Curiel	Drug Resistance Updates	2012
Growth of HepG2 Cells was Suppressed Through Modulation of STAT6/IL-4 and IL-10 in RAW 264.7 Cells Treated by Phytoglycoprotein (38 kDa) J Lee, KT Lim	Inflammation	2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice V Hurez, BJ Daniel, L Sun, AJ Liu, SM Ludwig, MJ Kious, SR Thibodeaux, S Pandeswara, K Murthy, CB Livi, S Wall, MJ Brumlik, T Shin, B Zhang, TJ Curiel	Cancer research	2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma R Brown, H Suen, J Favaloro, S Yang, PJ Ho, J Gibson, D Joshua	OncoImmunology	2012
Using antimicrobial adjuvant therapy in cancer treatment: a review K Alibek, A Bekmurzayeva, A Mussabekova, B Sultankulov	Infectious agents and cancer	2012
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1 JL McClellan, JM Davis, JL Steiner, RT Enos, SH Jung, JA Carson, MM Pena, KA Carnevale, FG Berger, EA Murphy	American journal of physiology. Gastrointestinal and liver physiology	2012
MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function H Fayyad-Kazan, R Rouas, M Fayyad-Kazan, R Badran, NE Zein, P Lewalle, M Najar, M Najar, E Hamade, F Jebbawi, M Merimi, P Romero, A Burny, B Badran, P Martiat	The Journal of biological chemistry	2012
In vitro-activated tumor-bearing host T cells and the effectiveness of tumor vaccine immunotherapy Li QL, Gao SF, Wang YP, Ma J, Feng CX, Wang Y, Wang YL	Annals of Saudi medicine	2012
Expression of Death Receptor 6 by Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer Barua A, Yellapa A, Bahr JM, Abramowicz JS, Edassery SL, Basu S, Rotmensch J, Bitterman P	Translational oncology	2012
[Prostate carcinoma: vaccination as a new option for treatment]. Bedke J, Gouttefangeas C, Stenzl A	Der Urologe A	2012
The Role of MicroRNAs in Regulatory T Cells and in the Immune Response TY Ha	Immune Network	2011
Cytokines in cancer immunotherapy S Lee, K Margolin	Cancers	2011
Stem Cell Transplantation for Indolent Lymphoma and Chronic Lymphocytic Leukemia JG Gribben, C Hosing, DG Maloney	Biology of Blood and Marrow Transplantation	2011
Autoimmune mediated regulation of ovarian tumor growth CZ Altuntas, R Jaini, P Kesaraju, D Jane-wit, JM Johnson, K Covey, CA Flask, M Dutertre, JY Picard, VK Tuohy	Gynecologic Oncology	2011
Timing Is Critical for an Effective Anti-Metastatic Immunotherapy: The Decisive Role of IFNγ/STAT1-Mediated Activation of Autophagy J Yan, ZY Wang, HZ Yang, HZ Liu, S Mi, XX Lv, XM Fu, HM Yan, XW Zhang, QM Zhan, ZW Hu	PloS one	2011
Influence of Dietary Components on Regulatory T Cells S Issazadeh-Navikas, R Teimer, R Bockermann	Molecular Medicine	2011
Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model T Onoe, H Kalscheuer, N Danzl, M Chittenden, G Zhao, YG Yang, M Sykes	Journal of immunology (Baltimore, Md. : 1950)	2011
Cancer immunology--analysis of host and tumor factors for personalized medicine S Ogino, J Galon, CS Fuchs, G Dranoff	Nature Reviews Clinical Oncology	2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma S Telang, MA Rasku, AL Clem, K Carter, AC Klarer, WR Badger, RA Milam, SN Rai, J Pan, H Gragg, BF Clem, KM McMasters, DM Miller, J Chesney	BMC Cancer	2011
Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer PY Pan, G Ma, KJ Weber, J Ozao-Choy, G Wang, B Yin, CM Divino, SH Chen	Cancer research	2010
Anti-HER2 vaccines: new prospects for breast cancer therapy MZ Ladjemi, W Jacot, T Chardès, A Pèlegrin, I Navarro-Teulon	Cancer Immunology, Immunotherapy	2010
Immunization delivered by lentiviral vectors for cancer and infectious diseases B Hu, A Tai, P Wang	Immunological Reviews	2010
Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization Q Zhou, H Xiao, Y Liu, Y Peng, Y Hong, H Yagita, P Chandler, DH Munn, A Mellor, N Fu, Y He	Journal of immunology (Baltimore, Md. : 1950)	2010
Human Regulatory T Cells in Autoimmune Diseases GL Cvetanovich, DA Hafler	Current Opinion in Immunology	2010
Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes T Alvaro, L la Cruz-Merino, F Henao-Carrasco, JL Rodríguez, DV Baz, MC de Villena, M Provencio	Journal of Biomedicine and Biotechnology	2010
DNA vaccines: developing new strategies against cancer D Fioretti, S Iurescia, VM Fazio, M Rinaldi	Journal of biomedicine & biotechnology	2010
Immunologic mechanisms in RCC and allogeneic renal transplant rejection J Bedke, A Stenzl	Nature Reviews Urology	2010
CD8+ Tregs in lupus, autoimmunity, and beyond RK Dinesh, BJ Skaggs, AL Cava, BH Hahn, RP Singh	Autoimmunity Reviews	2010
Targeting inhibitory pathways in cancer immunotherapy MO Lasaro, HC Ertl	Current Opinion in Immunology	2010
The epidemic of nonmelanoma skin cancer and the widespread use of statins: Is there a connection? L Mascitelli, F Pezzetta, MR Goldstein	Dermato-endocrinology	2010
An autoimmune-mediated strategy for prophylactic breast cancer vaccination R Jaini, P Kesaraju, JM Johnson, CZ Altuntas, D Jane-Wit, VK Tuohy	Nature Medicine	2010
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors S Mariucci, B Rovati, M Manzoni, MG Porta, G Comolli, S Delfanti, M Danova	Clinical and Experimental Medicine	2010
B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses PY Lin, L Sun, SR Thibodeaux, SM Ludwig, RK Vadlamudi, VJ Hurez, R Bahar, MJ Kious, CB Livi, SR Wall, L Chen, B Zhang, T Shin, TJ Curiel	Journal of immunology (Baltimore, Md. : 1950)	2010
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer and prognosis: cohort study and literature review K Nosho, Y Baba, N Tanaka, K Shima, M Hayashi, JA Meyerhardt, E Giovannucci, G Dranoff, CS Fuchs, S Ogino	The Journal of Pathology	2010
Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts S Bhattacharyya, DM Hossain, S Mohanty, GS Sen, S Chattopadhyay, S Banerjee, J Chakraborty, K Das, D Sarkar, T Das, G Sa	Cellular and Molecular Immunology	2010
Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage VL Green, A Alexandropoulou, MB Walker, AA Walker, DM Sharp, LG Walker, J Greenman	Experimental and therapeutic medicine	2010
Costimulator B7-DC Attenuates Strong Th2 Responses Induced by Nippostrongylus brasiliensis K Ishiwata, N Watanabe, M Guo, K Tomihara, MJ Brumlik, H Yagita, D Pardoll, L Chen, T Shin	Journal of immunology (Baltimore, Md. : 1950)	2010
JPEG2000 for automated quantification of immunohistochemically stained cell nuclei: a comparative study with standard JPEG format. Lejeune M, López C, Bosch R, Korzyńska A, Salvadó MT, García-Rojo M, Neuman U, Witkowski Ł, Baucells J, Jaén J	Virchows Archiv : an international journal of pathology	2010
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity U Petrausch, SM Jensen, C Twitty, CH Poehlein, DP Haley, EB Walker, BA Fox	Journal of immunology (Baltimore, Md. : 1950)	2009
Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells M Mandapathil, B Hilldorfer, MJ Szczepanski, M Czystowska, M Szajnik, J Ren, S Lang, EK Jackson, E Gorelik, TL Whiteside	The Journal of biological chemistry	2009
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis D Hirschhorn-Cymerman, GA Rizzuto, T Merghoub, AD Cohen, F Avogadri, AM Lesokhin, AD Weinberg, JD Wolchok, AN Houghton	Journal of Experimental Medicine	2009
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma W Maes, GG Rosas, B Verbinnen, L Boon, SD Vleeschouwer, JL Ceuppens, SW van Gool	Neuro-oncology	2009
Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors KA Smith, BL Meisenburg, VL Tam, RR Pagarigan, R Wong, DK Joea, L Lantzy, MA Carrillo, TM Gross, UM Malyankar, CS Chiang, DM Silva, TM Kündig, WM Kast, Z Qiu, A Bot	Clinical cancer research	2009
The role of regulatory T cells in cancer TY Ha	Immune Network	2009
Immunotherapy for liver tumors: present status and future prospects P Matar, L Alaniz, V Rozados, JB Aquino, M Malvicini, C Atorrasagasti, M Gidekel, M Silva, OG Scharovsky, G Mazzolini	Journal of Biomedical Science	2009
Regulatory T cells and immune tolerance to tumors X Cao	Immunologic Research	2009
Blocking TLR2 activity attenuates pulmonary metastases of tumor HZ Yang, B Cui, HZ Liu, S Mi, J Yan, HM Yan, F Hua, H Lin, WF Cai, WJ Xie, XX Lv, XX Wang, BM Xin, QM Zhan, ZW Hu	PloS one	2009
Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model D Liao, Y Luo, D Markowitz, R Xiang, RA Reisfeld	PloS one	2009
Targeting a Mimotope Vaccine to Activating Fcγ Receptors Empowers Dendritic Cells to Prime Specific CD8 + T Cell Responses in Tumor-Bearing Mice M Gil, M Bieniasz, A Wierzbicki, BJ Bambach, H Rokita, D Kozbor	Journal of immunology (Baltimore, Md. : 1950)	2009
Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival MJ Dobrzanski, KA Rewers-Felkins, IS Quinlin, KA Samad, CA Phillips, W Robinson, DJ Dobrzanski, SE Wright	Clinical Immunology	2009
Cellular immunotherapy for ovarian cancer MJ Cannon, TJ O'Brien	Expert Opinion on Biological Therapy	2009
Modulators of arginine metabolism support cancer immunosurveillance G Capuano, N Rigamonti, M Grioni, M Freschi, M Bellone	BMC Immunology	2009
CCL2 Blockade Augments Cancer Immunotherapy ZG Fridlender, G Buchlis, V Kapoor, G Cheng, J Sun, S Singhal, MC Crisanti, LC Wang, D Heitjan, LA Snyder, SM Albelda	Cancer research	2009
Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma HU Kasper, U Drebber, DL Stippel, HP Dienes, A Gillessen	World journal of gastroenterology : WJG	2009
Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance X Cao, K Leonard, LI Collins, SF Cai, JC Mayer, JE Payton, MJ Walter, D Piwnica-Worms, RD Schreiber, TJ Ley	Cancer research	2009
Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy AG Ramsay, AJ Clear, G Kelly, R Fatah, J Matthews, F Macdougall, TA Lister, AM Lee, M Calaminici, JG Gribben	Blood	2009
Is complement good or bad for cancer patients? A new perspective on an old dilemma MM Markiewski, JD Lambris	Trends in Immunology	2009
Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma M Lejeune, T Alvaro	Haematologica	2009
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells CM Chuang, T Hoory, A Monie, A Wu, MC Wang, CF Hung	Vaccine	2009
The importance of the age factor in cancer vaccination at older age C Gravekamp	Cancer Immunology, Immunotherapy	2009
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma H Quach, D Ritchie, AK Stewart, P Neeson, S Harrison, MJ Smyth, HM Prince	Leukemia	2009
Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction S Biswas, K Biswas, A Richmond, J Ko, S Ghosh, M Simmons, P Rayman, B Rini, I Gill, CS Tannenbaum, JH Finke	Journal of immunology (Baltimore, Md. : 1950)	2009
OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age CE Ruby, AD Weinberg	Journal of immunology (Baltimore, Md. : 1950)	2009
CD4+ CD25+ regulatory T cells control TRAIL- dependent cytotoxicity of tumor- infiltrating dendritic cells Stephan Roux, Lionel Apetoh, Sylvain Ladoire, Grégoire Mignot, Pierre-Emmanuel Puig, Laurence Zitvogel, François Martin, Bruno Chauffert, Hideo Yagita, Eric Solary, François Ghiringhelli	Journal of Clinical Investigation	2008
Transient T cell depletion causes regression of melanoma metastases MA Rasku, AL Clem, S Telang, B Taft, K Gettings, H Gragg, D Cramer, SC Lear, KM McMasters, DM Miller, J Chesney	Journal of Translational Medicine	2008
Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes MV Shah, R Zhang, R Irby, R Kothapalli, X Liu, T Arrington, B Frank, NH Lee, TP Loughran	Blood	2008
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma SA Quezada, KS Peggs, TR Simpson, Y Shen, DR Littman, JP Allison	Journal of Experimental Medicine	2008
Adoptive immunotherapy: good habits instilled at youth have long-term benefits CM Paulos, MM Suhoski, G Plesa, T Jiang, S Basu, TN Golovina, S Jiang, NA Aqui, DJ Powell, BL Levine, RG Carroll, JL Riley, CH June	Immunologic Research	2008
Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells RG Carroll, C Carpenito, X Shan, G Danet-Desnoyers, R Liu, S Jiang, SM Albelda, T Golovina, G Coukos, JL Riley, ZL Jonak, CH June	PloS one	2008
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy CM Diaz-Montero, ML Salem, MI Nishimura, E Garrett-Mayer, DJ Cole, AJ Montero	Cancer Immunology, Immunotherapy	2008
CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis GM Han, NJ O'Neil-Andersen, RB Zurier, DA Lawrence	Cellular Immunology	2008
PPARgamma Inhibitors as Novel Tubulin-Targeting Agents KL Schaefer	PPAR Research	2008
TGF-β AND TUMORS – AN ILL-FATED ALLIANCE NM Moutsopoulos, J Wen, SM Wahl	Current Opinion in Immunology	2008
Regulatory T cells and treatment of cancer TJ Curiel	Current Opinion in Immunology	2008
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease C Bergmann, L Strauss, Y Wang, MJ Szczepanski, S Lang, JT Johnson, TL Whiteside	Clinical cancer research	2008
Development of multi-epitope vaccines targeting wild-type (wt) sequence p53 peptides AB DeLeo, TL Whiteside	Expert Review of Vaccines	2008
Do statins prevent or promote cancer? Goldstein MR, Mascitelli L, Pezzetta F	Current Oncology	2008
Regulatory and Conventional CD4+ T cells Show Differential Effects Correlating with PD-1 and B7-H1 Expression After Immunotherapy Alderson KL, Zhou Q, Berner V, Wilkins DE, Weiss JM, Blazar BR, Welniak LA, Wiltrout RH, Redelman D, Murphy WJ	Journal of immunology (Baltimore, Md. : 1950)	2008
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity C Ménard, F Martin, L Apetoh, F Bouyer, F Ghiringhelli	Cancer Immunology, Immunotherapy	2008
Series overview: Harnessing the immune system to treat cancer Nina Bhardwaj	Journal of Clinical Investigation	2007
Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity A Kato, RP Schleimer	Current Opinion in Immunology	2007

Advertisement